RAPT Therapeutics (RAPT) P/E (2019 - 2026)
RAPT Therapeutics (RAPT) P/E from Dec 31, 2019 to Mar 4, 2026. The TTM RAPT Therapeutics (RAPT) P/E is -21.22. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of RAPT Therapeutics (RAPT)
| Year | P/E | Change |
|---|---|---|
| 2026 | -21.22 | +71.30% |
| 2025 | -12.39 | +197.18% |
| 2024 | -4.17 | -93.98% |
| 2023 | -69.21 | +12.33% |
| 2022 | -61.62 | -50.39% |
| 2021 | -124.19 | +76.82% |
| 2020 | -70.23 | -80.75% |
| 2019 | -364.79 | N/A |
Comparison RAPT Therapeutics (RAPT) P/E with competitors
RAPT Therapeutics (RAPT) P/E is -21.22.